Diagnostic and Prognostic Utility of a DNA Hypermethylated Gene Signature in Prostate Cancer

We aimed to identify a prostate cancer DNA hypermethylation microarray signature (denoted as PHYMA) that differentiates prostate cancer from benign prostate hyperplasia (BPH), high from low-grade and lethal from non-lethal cancers. This is a non-randomized retrospective study in 111 local Asian men...

Descripción completa

Detalles Bibliográficos
Autores principales: Goh, Liang Kee, Liem, Natalia, Vijayaraghavan, Aadhitthya, Chen, Gengbo, Lim, Pei Li, Tay, Kae-Jack, Chang, Michelle, Low, John Soon Wah, Joshi, Adita, Huang, Hong Hong, Kalaw, Emarene, Tan, Puay Hoon, Hsieh, Wen-Son, Yong, Wei Peng, Alumkal, Joshi, Sim, Hong Gee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3953552/
https://www.ncbi.nlm.nih.gov/pubmed/24626295
http://dx.doi.org/10.1371/journal.pone.0091666

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3953552/
https://www.ncbi.nlm.nih.gov/pubmed/24626295
http://dx.doi.org/10.1371/journal.pone.0091666

Ejemplares similares